Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Jul 10, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$6.06B
sum of reported positions
Reported positions
484
Changes vs prior quarter
533
35 new · 78 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 308 measured positions in 8 quarters, the typical new or larger position finished −1.9 pts against the S&P 500 and 45% finished ahead of it. For scale, across all 503 funds with a result: −2.1 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
2,466 institutions report a stake.
Also among the 20 largest: Capital World Investors, Capital International Investors, Primecap Management Co
3,487 institutions report a stake.
Also among the 20 largest: Capital Research Global Investors
| Company | Shares | Value | Weight | Of company |
|---|---|---|---|---|
| $108M | 1.8% | 0.03% | ||
| $101M | 1.7% | 0.02% | ||
| $95.5M | 1.6% |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
In its latest 13F, with holdings as of Jun 30, 2026 (Q2 2026), Wedge Capital Management L L P reported 484 positions worth $6.06B. The largest: KLA Corporation (KLAC), 1.8%; Applied Materials (AMAT), 1.7%; Lam Research (LRCX), 1.6%; Amphenol (APH), 1.5%; Alphabet (GOOGL), 1.4%. The five largest make up 8% of the reported portfolio.
Change in the reported value against the quarter before.

Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $5.42B | $6.06B |
| Positions | 527 | 484 |
| Biggest line | — | KLA Corporation 2% |

3,096 institutions report a stake.
2,318 institutions report a stake.
Also among the 20 largest: Capital International Investors, Capital Research Global Investors
6,246 institutions report a stake.
Also among the 20 largest: Capital World Investors, Berkshire Hathaway, Capital Research Global Investors
2,124 institutions report a stake.
Also among the 20 largest: LSV Asset Management
| 0.02% |
| $93.2M | 1.5% | 0.02% |
| $83.4M | 1.4% | 0.00% |
| $82.9M | 1.4% | 0.03% |
| $82.6M | 1.4% | 1.3% |
| $82.5M | 1.4% | 1.1% |
| $82.4M | 1.4% | 0.04% |
| $81.8M | 1.3% | 0.21% |
| $80.6M | 1.3% | 0.14% |
| $80M | 1.3% | 0.29% |
| $79.3M | 1.3% | 0.03% |
| $77.8M | 1.3% | 0.36% |
| $77.6M | 1.3% | 0.53% |
| $75.6M | 1.2% | 0.06% |
| $75.3M | 1.2% | 0.00% |
| $74.9M | 1.2% | 0.03% |
| $74.2M | 1.2% | 0.35% |
| $72.4M | 1.2% | 0.36% |
| $72.3M | 1.2% | 0.67% |
| $71.9M | 1.2% | 0.02% |
| $71.6M | 1.2% | 0.40% |
| $70.8M | 1.2% | 0.23% |
| $70.4M | 1.2% | 0.12% |
CVS Health (CVS)
360K → 302K shares (−16%)
Labcorp (LH)
108K → 110K shares (+2%)
Jazz Pharmaceuticals (JAZZ)
160K → 127K shares (−21%)
Bristol Myers Squibb (BMY)
493K → 528K shares (+7%)
Altria (MO)
455K → 418K shares (−8%)
Cencora (COR)
81K → 106K shares (+31%)
Regeneron Pharmaceuticals (REGN)
40K → 48K shares (+20%)
GE HealthCare (GEHC)
361K → 461K shares (+28%)
Viatris (VTRS)
1.94M → 1.86M shares (−5%)
McKesson Corporation (MCK)
32K → 39K shares (+23%)
Solventum (SOLV)
384K → 379K shares (−1%)
Eversource Energy (ES)
311K → 352K shares (+13%)
Timken (TKR)
171K → 147K shares (−14%)
Portland General Electric (POR)
442K → 377K shares (−15%)
Gates Industrial Corp plc
646K → 679K shares (+5%)
Allison Transmission (ALSN)
136K → 147K shares (+8%)
Matson, Inc. (MATX)
89K → 84K shares (−6%)
Spire (SR)
213K → 208K shares (−3%)
Acuity Brands (AYI)
39K → 43K shares (+9%)
ADT Inc. (ADT)
2.07M → 2.44M shares (+18%)
Mueller Industries (MLI)
127K → 129K shares (+2%)
Oshkosh (OSK)
77K → 101K shares (+31%)
Evergy (EVRG)
210K → 175K shares (−17%)
Masco (MAS)
173K → 185K shares (+7%)
DTE Energy (DTE)
118K → 99K shares (−17%)
KLA Corporation (KLAC): $108M, or 1.8% of the portfolio reported for Q2 2026.
Between its last two 13F reports, Wedge Capital Management L L P opened 35 new positions, added to 150, trimmed 270 and sold out of 78. The comparison is in share counts, so a price move alone does not count as buying or selling.
Its 13F for Q2 2026 adds up to $6.06B. That is not the whole firm: a 13F lists only US-listed shares and some options held at the end of the quarter, and leaves out cash, bonds, short positions and foreign holdings.
The report for Q2 2026 was filed on Jul 10, 2026. A manager has 45 days after the end of each quarter to file, so the holdings are always several weeks old when they become public.
On 308 positions it reported as new or larger over 8 quarters, the typical one finished −1.9 points against the S&P 500 after 90 days, and 45% finished ahead of it. Measured from the day each filing became public; history, not a forecast.
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.